U.S. Cannabis Market (By End-use: Medical, Recreational, Industrial; By Source: Marijuana, Hemp; By Derivative: CBD, THC) -Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Cannabis Market 

5.1. COVID-19 Landscape: U.S. Cannabis Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global U.S. Cannabis Market, By End-use

8.1. U.S. Cannabis Market, by End-use, 2022-2030

8.1.1 Medical

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Recreational

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Industrial

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global U.S. Cannabis Market, By Source

9.1. U.S. Cannabis Market, by Source, 2022-2030

9.1.1. Marijuana

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Hemp

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global U.S. Cannabis Market, By Derivative 

10.1. U.S. Cannabis Market, by Derivative, 2022-2030

10.1.1. CBD

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. THC

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Others

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global U.S. Cannabis Market, Regional Estimates and Trend Forecast

11.1. U.S.

11.1.1. Market Revenue and Forecast, by End-use (2017-2030)

11.1.2. Market Revenue and Forecast, by Source (2017-2030)

11.1.3. Market Revenue and Forecast, by Derivative (2017-2030)

Chapter 12. Company Profiles

12.1. Canopy Growth Corporation

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. GW Pharmaceuticals, plc

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Aurora Cannabis, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Aphria, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Cronos Group

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Tilray

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms